Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06643611 · ClinicalTrials.gov registry record · NA
Addressing Disparities in Diabetes Care
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06643611 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants.
The verdict
NCT06643611, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research is to find out if using a continuous glucose monitor and working with a clinical pharmacist can help improve the health of uninsured minority patients with type 2 diabetes.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Continuous Glucose Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-11-18 |
| Est. Completion | 2025-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06643611
The ClinicalTrials.gov registry entry for NCT06643611 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT06643611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06643611 about?
NCT06643611 is a clinical study titled "Addressing Disparities in Diabetes Care". The purpose of this research is to find out if using a continuous glucose monitor and working with a clinical pharmacist can help improve the health of uninsured minority patients with type 2 diabetes.
What is the current status of trial NCT06643611?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-18. Estimated completion is 2025-09-22.
What interventions are being tested in trial NCT06643611?
The interventions under investigation include: Usual Care (BEHAVIORAL), Continuous Glucose Monitor (BEHAVIORAL).
Who is sponsoring clinical trial NCT06643611?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.